Malignant disease as an incidental finding at 18F-FDG-PET/CT scanning in patients with granulomatous lung disease
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F15%3A33156742" target="_blank" >RIV/61989592:15110/15:33156742 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1097/MNM.0000000000000274" target="_blank" >http://dx.doi.org/10.1097/MNM.0000000000000274</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1097/MNM.0000000000000274" target="_blank" >10.1097/MNM.0000000000000274</a>
Alternative languages
Result language
angličtina
Original language name
Malignant disease as an incidental finding at 18F-FDG-PET/CT scanning in patients with granulomatous lung disease
Original language description
PURPOSE: Fluorine-18 fluorodeoxyglucose (18F-FDG)-PET/computed tomography (CT) is used for assessment of the extent and activity of disease in patients with inflammatory granulomatous lung disease, in particular sarcoidosis and tuberculosis. The aim of this retrospective analysis was to assess the value of 18F-FDG-PET/CT in the identification of previously unknown malignant disease during routine investigation of granulomatous lung disease. MATERIALS AND METHODS: From July 2008 to December 2013, a totalof 122 patients with tuberculosis (76 male and 46 female patients; age range 19.6-88.6 years, mean 52.8+-16.6 years) and 85 patients with sarcoidosis (46 male and 39 female patients; age range 17.8-76.5 years, mean 48.6+-13.8 years) underwent 18F-FDG-PET/CT. Reports were generated in consensus by both a nuclear medicine physician and a radiologist. Possibly malignant findings underwent biopsies and/or follow-up. Quantitative parameters (maximum standardized uptake value) were pooled and
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Nuclear Medicine Communications
ISSN
0143-3636
e-ISSN
—
Volume of the periodical
36
Issue of the periodical within the volume
5
Country of publishing house
GB - UNITED KINGDOM
Number of pages
8
Pages from-to
430-437
UT code for WoS article
—
EID of the result in the Scopus database
—